Next Article in Journal
Sonic and Impact Test for Structural Assessment of Historical Masonry
Next Article in Special Issue
Directed Silica Co-Deposition by Highly Oxidized Silver: Enhanced Stability and Versatility of Silver Oxynitrate
Previous Article in Journal
A Cloud Image Data Protection Algorithm with Multilevel Encryption Scheme and Automated- Selection Mechanism
Previous Article in Special Issue
New Local Drug Delivery with Antibiotic in the Nonsurgical Treatment of Periodontitis—Pilot Study
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Effect of Tinospora cordifolia-Derived Phytocomponents on Cancer: A Systematic Review

Department of Oral Pathology and Microbiology, Maratha Mandal’s NATHAJIRAO G. HALGEKAR Institute of Dental Sciences and Research Centre, Belgaum 590010, India
Department of Maxillofacial Surgery, College of Dental Sciences, Rajiv Gandhi University of Health Sciences, Davanagere 577004, India
Department of Dental Sciences, Oral Pathology Division, College of Dentistry, King Khalid University, Abha 62529, Saudi Arabia
Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia
Department of Dental Health, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Saudi Arabia
Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai 600130, India
Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia
Author to whom correspondence should be addressed.
Appl. Sci. 2019, 9(23), 5147;
Submission received: 28 October 2019 / Revised: 22 November 2019 / Accepted: 26 November 2019 / Published: 28 November 2019


The major cancer therapeutic modalities include surgery, chemotherapy and radiotherapy. Although these treatment regimens have played a significant role in effectively inhibiting cancer, their associated morbidity reduces the overall quality of life. Thus, researchers are striving to identify any alternate therapeutic approach capable of inhibiting cancer without eliciting the added morbidity. Among the alternate cancer therapeutics being researched, much importance is being given to the use of plants due to the presence of a wide variety of anti-carcinogenic compounds. Tinospora cordifolia (Tc) is one such plant and has shown to exhibit anti-carcinogenic properties. The present review aimed to systematically analyze published data on the effect of Tinospora cordifolia-derived phytocomponents on cancer. PubMed, Scopus, Web of Science, Embase and Cochrane library were searched using the keywords Tinospora cordifolia; anticancer; phytocomponents until March 20, 2019. In vivo and in vitro original studies in the English language were included. Of the 342 articles identified, only 25 articles met the selection criteria and were included in the review. Significant anti-carcinogenic properties were exhibited by Tinospora cordifolia-derived phytocompounds including palmative, berberine, new clerodane furanoditerene glycoside, arabinogalactan, phenolic compounds and epoxy cleodane diterpene. No significant side effects have been elicited with its use. Based on the data from the included studies, Tinospora cordifolia could be a natural therapeutic agent for cancer, provided its anti-carcinogenic properties can be elicited consistently at a large scale in clinical trials.

1. Introduction

Cancer is a growing economic burden worldwide. The Globocan 2018 database estimates 18.1 million new cancer cases and 9.6 million cancer-related deaths [1]. This frightening and dreadful statistic has motivated the hunt for efficacious anticancer agents. Current therapeutic modalities in cancer, including surgery, chemotherapy, and radiotherapy have shown to be associated with significant morbidity [2]. Thus, there is much interest shown in the advent of alternative therapeutics including medicinal plants. Although several studies have explored the therapeutic benefits of natural plant-based products, there is a relative deficit in the number of systematic reviews available, especially with respect to plants present in remote areas such as the Tinospora genus. In the Tinospora genus, only Tinospora cordifolia (Tc), has shown to exhibit anti-carcinogenic properties. Thus, Tc was selected as the subject of the review. Tc belongs to Menispermaceae family (universally named as “Guduchi”/ Giloy in Sanskrit). It is a deciduous climbing shrub with typical greenish-yellow flowers, found at higher altitudes like India, Myanmar and Sri Lanka. Tc has shown to exhibit several unique features, distinguishing them from other closely related species in the Tinospora genus, including Tinospora malabarica (Tm). Tc has an ash-colored cork, higher lenticels, nodes and internode, and a lower mucilage content than Tm. A variety of active components are derived from Tc including alkaloids, steroids, diterpenoid lactones, aliphatics, and glycoside. Apart from the anti-neoplastic properties, Tc is also shown to exhibit anti-diabetic, anti-periodic, anti-spasmodic, anti-inflammatory, anti-arthritic, antioxidant, anti-allergic, anti-stress, anti-leprotic, anti-malarial, hepatoprotective and immunomodulatory properties [3,4]. The present review systematically analyzes the published data assessing the effects of Tc-derived phytocomponents on cancer.

2. Methods

2.1. Inclusion Criteria

In vitro cell line and in vivo animal model studies in the English language assessing the effect of the Tc-derived phytocomponents on cancer.

2.2. Exclusion Criteria

Narrative reviews, systematic reviews, meta-analysis, letters, editorials, conference abstracts, articles in languages other than English.

2.3. Information Sources and Search Strategies

PubMed, Scopus, Web of Science, Embase and Cochrane library were searched using the keywords Tinospora cordifolia; anticancer; and phytocomponents until March, 2019.

2.4. Study Selection

The review was conducted in two steps. In the first step, the titles and abstracts of the articles identified from the databases were screened to remove any duplicates and irrelevant articles. The full texts of the articles selected from the first step were assessed in the second step using the inclusion criteria. Both steps one and two were conducted by two reviewers (B.D and H.V.B) independently. The kappa coefficient was assessed to determine the inter-observer reliability between the two reviewers for steps one and two.

3. Results

Selected Studies: A total of 342 articles (PubMed—14, Scopus—36, Web of Science—20, Embase—203, Cochrane—69) were identified using the keywords. Titles and the abstract of the identified articles were screened to remove any duplicates or irrelevant articles in step one. Only 50 articles were included in step two. Based on the full-text assessment of these 50 articles, only 25 articles were found to satisfy the inclusion criteria and were included in the systematic review. Figure 1 illustrates the search strategy employed. The kappa coefficient for steps one and two was found to be 0.9 and 1, respectively. Table 1; Table 2 respectively summarize the overall in vitro and in vivo effect of Tc-derived phytocomponents on cancer. The various phytocomponents present in the different parts of Tc, along with their anti-carcinogenic effects on cancer (both in vitro and in vivo), are elaborated in detail in the discussion.

4. Discussion

Phytocomponents are natural components capable of exerting a therapeutic effect on disease entities, including cancer. Unlike conventional cytotoxic chemotherapeutic agents, phytocomponents have shown to inhibit cancer cells without eliciting systemic toxicity. Tc is one such plant, whose phytocomponents have shown therapeutic value against several diseases, including cancer [3]. Thus, the present manuscript systematically reviewed the published literature to provide comprehensive data on the effect of Tc on cancer based on both in vitro and in vivo experimental models. Assessment of the in vitro studies has shown Tc to have a potent anti-carcinogenic property based on induction of apoptosis, cell cycle arrest, anti-migratory, anti-metastatic effect, upregulation of cellular senescence and cell growth inhibition in cancer cells (Table 1). Assessment of in vivo studies has shown anti-carcinogenic properties in the form of apoptosis induction, decrease in the expression of proliferative markers, an overall reduction in disease burden, and recurrence rate, with a significant increase in the survival rate (Table 2).

4.1. Parts of the Tc with Anti-Carcinogenic Effect

Phytocompounds have been isolated from all parts of Tc including the body of the plant, leaves and stem [4]. The stem of Tc has shown to contain most of the high phytocomponents, hence, most of the included studies have preferred the use of the stem. Rashmi KC et al. used Tc leaves, due to the presence of bis(2-ethylhexyl)-1H-pyrrole-3,4-dicarboxylate. Some studies have even used the whole plant [13].

4.2. Tc-Based Extracts

The various parts of Tc were subjected to different types of extracts for isolating the bioactive phytocomponents, including the alcoholic extract and aqueous extract. For alcoholic extracts, the parts were dried, ground in an electrical grinder and dissolved in either ethanol or methanol. Soxhlet apparatus was used for the extracts. For aqueous extracts, either distilled water or double-distilled water was used. Phytocomponents isolation was also accomplished using solvents like petroleum ether, chloroform, ethyl acetate, and acetone with alcohol [8,10]. Some authors preferred using both aqueous as well as alcoholic extracts [7,10]. Hexane extracts utilized solvents including hexane, benzene, chloroform and ethyl acetate [24] Singh B et al. used phenol to extract the dried leaves and stems of Tc [18]. Overall, most of the included studies preferred alcoholic extracts.

4.3. Dose Effect of Phytocomponents

According to the US National Cancer Institute, an IC50 value (drug concentration required for 50% inhibition in vitro) of less than 100 µg/mL from a medicinal plant is sufficient to be considered as an anticancer agent [29]. Components of such plants are isolated and characterized to delineate their bioactive molecules. The methanolic extracts of Tc have shown to exhibit an IC50 value of less than 100 µg/mL [29]. Sharma N used 1.5 kg of dried, crushed Tc soaked in 4.5 liters and found an IC50 value of less than 100 µg/mL [6]. Priya M S et al. used varying dosage (200, 400 and 600 µg/mL) of Tc, revealing dose-dependent inhibition [7]. Bala M et al. used 2 kg of dried stem in 80% ethanol extract. They extracted three phytocomponents and elicited an IC50 value of less than 100 µg/ml [9]. Maliakkal et al. used 2 kg of the dried crushed stem through alcohol extract and observed a dose which depended on cytotoxicity, with an ideal IC50 value of less than 100 µg/mL. They also showed that combining different phytocomponents resulted in a profound anti-carcinogenic effect [11]. Ansari et al. used 10 kg of 50% methanolic extract of Tc. The extract showed the anti-carcinogenic effect, while its rutin concentration was found to be higher than quercetin [15]. Ali H et al. found the phytocomponent palmatine showed anticancer effect against environmentally induced carcinogenesis. Jagetia et al. observed that combining the various alkaloid with berberine increased the antineoplastic effect. Thus, in addition to the dose-dependent effect, the overall anti-carcinogenic effect also depended on the type, number and dosage of the used phytocomponents [7,14,15,22].

4.4. Phytocomponents and Its Mechanism of Action against Cancer Cells

The active phytocomponents of Tc include alkaloids, glycosides, steroids, aliphatic compounds, essential oils, a mixture of fatty acid, calcium, phosphorous, protein and polysaccharides [4]. The various phytocomponents identified from the studies analyzed in the systematic review included berberine, new clerodane furanodiptherineglycosidae, elligic acid, kaempferol, N-formylannonain, magnoflorine, jatrorrhizine palmatine, 11-hydroxymustakone, cordifolioside A, tinocordiside, yangambin, anthraquinones, terpenoids, saponins and phenol, pyrrole-based small molecules, quercetin and rutin, arabinogalectian, palmatine, clerodane-derived diterpenoids and hexane fractions. These phytocomponents induced anticancer effect via mitochondrial-mediated apoptosis, cytotoxic activity, mutagenic activity, reduction in tumor size, triggering reactive oxygen species, decreased gene expression of the cell cycle, effectively inhibiting cancer proliferation [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23]. The mechanism of action of Tc depends on the phytocomponents used. The new clerodane furanodiptherineglycosidae exhibits anticancer activity through induction of mitochondrial-mediated apoptosis by triggering reactive oxygen species and autophagy [6]. Phenolic compounds have genoprotective and antioxidant effects on cancer cells [8]. Tc ethanolic extracts induced apoptosis via. increased sub G0 phase without altering cell cycle [11]. Arabinogalactans present in aqueous extracts of Tc shown to produce immunological activity and cytotoxic activity. Phenols have shown antimutagenic and anti-malignant effects. Flavanoids have a chemopreventive role in cancer. Pyrrole-based molecules induced apoptosis and cytotoxic effects [13]. Palmatine showed enhanced antioxidant activity by the increase in the level of antioxidant enzymes and also showed inhibition of lipid peroxidation showing role in detoxification pathway [20]. Berberine has shown to inhibit tumor cell growth by a reduction in the secretion of growth factors [5]. Hexane fractions have induced apoptosis via caspase 3-activated DNase [24]. Leyo et al. reported the polysaccharides in Tc to show antineoplastic effect by reducing the protein levels [25]. Epoxy-clerodane-diterpene blocks the carcinogen metabolic activation and enhances carcinogen detoxification. Singh N et al. reported Tc extracts have shown anticancer effect by direct tumoricidal actions [28]. Thus, Tc extracts have shown anti-carcinogenic properties through several mechanisms including induction of DNA damage, apoptosis, inhibiting topoisomerase II, clonogenicity, antioxidant activity, glutathione S transferase activity and increasing lipid peroxidase activity.

4.5. Anti-Carcinogenic Effect of Tc Phytocomponents

In vitro studies: In the included studies, the Tc-extracted phytocompounds were used in combination with conventional chemotherapeutics including: fluorouracil, cisplatin, paclitaxel, suramin, doxorubicin, mitomycin, adriamycin, and methotrexate. The Tc extract berberine (an alkaloid) has shown to inhibit cell cycle, differentiation, and epithelial–mesenchymal transition on HEP2 human laryngeal cancer cell lines [5]. New clerodane-furano-diterpene-glycoside obtained as an aqueous-alcoholic extract through bioassay-guided fractionation exhibited significant cytotoxic effect and induced apoptosis in human lung carcinoma (A549), prostate (PC-3), SF-269(CNS), melanoma (MDA-MB-435), colon cancer (HCT-116) and breast cancer (MCF-7) cell lines. It was observed the induction of apoptosis was Reactive oxygen species-mediated through mitochondria by activation of the caspase pathway [6]. Singh B et al. identified phenolic compounds from a fungal extract of endophytic fungus Cladosporium velox TN-9S isolated from the stem of Tc. Total phenol content was 730 µg gallic equivalents/mL as determined by Folin Ciocalteu reagent. The IC50 value was less than 100 µg/mL. These phenolic compounds have shown to exhibit a mild genoprotective potential against DNA damage on Chinese hamster ovary cell lines after the treatment with non-ionic surfactant nonylphenol. It was also noted that the endophyte’s capability to synthesize phytocomponent was similar to the host plant. Their non-mutagenic and non-cytotoxic nature was suggested to enhance the antioxidant and genoprotective potential [8]. Bala et al. identified the phytocompounds from Tc extracts such as N-formylannonain, magnoflorine, jatrorrhizine palmatine, 11-hydroxymustakone, cordifolioside A, tinocordiside and yangambin through spectroscopic analysis. These phytocompounds were shown to exhibit anti-cancer properties on several human cancer cell lines including KB (human oral squamous carcinoma), CHOK-1 (hamster ovary), HT-29 (human colon cancer) and SiHa (human cervical cancer). Bala et al. compared the anticancer activity for different fractions of the Tc extract. It was noted that combining the phytocompounds increased the anti-carcinogenic properties through a synergistic effect [9]. The ethanol phytofraction obtained from plant samples of Tc by Mishra R et al. were cytotoxic to IMR- 32 human neuroblastoma cancer cell lines. Analysis of the cellular and nuclear morphology through immunostaining revealed Tc induced apoptosis, increased expression of senescence markers. Anti-metastatic activity in the form of a reduced cell migration capacity was also observed. Protein assays result expressed the arrest of cells in the Go/G1 phase. Mishra R et al. extracted phytocomponents from Tc plant including anthraquinones, terpenoids, saponins and phenol. This component effectively inhibited the growth of prostate, ovary and breast cancer cell lines. Tc extracts were also shown to exhibit antiproliferative, apoptotic-inducing, anti-migratory and antimetastatic potential on glioma cells. [12]. Butanoic fractions (pyrrole-based small molecules) were shown to induce apoptosis on breast cancer cells. Rashmi KC et al. determined apoptotic induction by evaluation by various apoptotic markers, ROS generation, caspase activity, and cell cycle analyzing. They found phytocomponents of Tc extract having anticancer activity and also observed inhibition of tumor proliferation. Despite promising results, the major limitation of most of the abovementioned studies is that several key aspects, including the complete mechanism of action, signaling, and pharmacological actions were nor clearly delineated [13]. Quercetin and rutin belong to phenolic phytocomponents extracted from Tc showed antiproliferative activity and was confirmed on human breast cancer MDA-MB-231 cells through induction of apoptosis, expression of altered genes and checking for the levels of intracellular ROS. The pharmacokinetics profiles, pharmacodynamic profiles and preclinical evaluation are some examples of the ongoing research by the authors [15]. Table 1 provides a summary of the overall effects elicited by Tc against the various cell lines.
In vivo studies: Animals that are used for the study in this review include male or female Swiss albino mice injected with Ehrlich ascites cells; male BALB/c mice with benzopyrene-induced pulmonary tumor; DABA-induced mammary carcinogenesis female Sprague Dawley rats; freshwater air-breathing fish C. punctatus; Swiss albino with DABA-induced carcinoma, C57BL/6 mice injected by B16F-10 melanoma cell lines; and male Wistar albino-strain rats with hepatocellular carcinoma. Arabinogalactan, a polysaccharide, was shown to inhibit cancer in male BALB/c mice. The arabinogalactan and the stem extract of Tc were shown to have a higher anticancer effect than only Tc [18]. Mishra A et al. conducted a scientific evaluation of phenolic components such as ellagic acid and kaempferol obtained from Tc extracts. These components were shown to have a genoprotective effect on fresh-air-breathing fish as elicited by the observations made on the morphology of the nucleus. Injecting the extract of fungus of Tc plant and nonylphenol caused a drastic reduction in the nuclear abnormalities. [19] Hall et al. extracted alkaloid phytocomponent palmative from Tc and studied anticancer property against DMBA induced skin cancer. Palmative caused a gradual decrease in the bodyweight of tumor size. Palmatine phytocomponent was shown to enhance the antioxidant enzyme levels and also inhibit carcinogenesis when administrated orally. [20] Another alkaloid phytocomponent, berberine, showed tumor remission on Swiss albino mice. The study was conducted by Jagetia G C et al. The anticancer effect was dose dependent. The exact mechanism was unknown, and authors concluded that the combinational effect of the alkaloids caused a higher anticancer effect [21]. Phytocomponents including triterpenoids, alkaloids, pyrrole-based small molecules, hexane fraction and clerodane-derived diterpenoids were also shown to exhibit significant anti-carcinogenic effect in different cancer induced in animals by showing reduction in solid tumor growth [22,23,24,26,27,28]. Leyon P V and Kuttan G extracted polysaccharide from Tc to observe the metastatic effect on C55BL/6 mice and the highly metastatic melanoma cell line B16F-10. Significant inhibition was noted, and although the exact mechanism of action was not known, an antimitogenic effect through natural killer cell-mediated immune modulation was suggested as a possible pathway [25]. Table 2 provides a summary of the overall effects elicited by Tc against the various in vivo animal models.

5. Conclusions

Tc has been shown to contain several phytocomponents with significant anti-carcinogenic properties as elicited by the included in vitro and in vivo studies. Despite promising results in laboratory settings, the future scope of Tc application in cancer therapy depends primarily on the success of translating the in vitro and in vivo results on to the clinical trials. Thus, large-scale multicenter prospective studies are required to elicit the potential application of Tc in cancer therapy.

Author Contributions

Conceptualization, search strategy B.D., H.V.B., J.V.H., and A.W.H.A. Extraction of data from the included studies, analysis of the data- S.M., A.T.R., S.P. All authors were involved in drafting and editing the final manuscript.


This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
  2. Anastyuk, S.D.; Shevchenko, N.M.; Ermakova, S.P.; Vishchuk, O.S.; Nazarenko, E.L.; Dmitrenok, P.S.; Zvyagintseva, T.N. Anticancer activity in vitro of a fucoidan from the brown alga Fucusevanescens and its low-molecular fragments, structurally characterized by tandem mass-spectrometry. Carbohydr. Polym. 2012, 87, 186–194. [Google Scholar] [CrossRef]
  3. Saha, S.; Ghosh, S. Tinosporacordifolia: One plant, many roles. Anc. Sci. Life 2012, 31, 151–159. [Google Scholar]
  4. Tiwari, P.; Nayak, P.; Prusty, S.K.; Sahu, P. Phytochemistry and pharmacology of Tinosporacordifolia: A Review. Syst. Rev. Pharm. 2018, 9, 70–78. [Google Scholar] [CrossRef]
  5. Palmieri, A.; Iapichino, A.; Cura, F.; Scapoli, L.; Carinci, F.; Mandrone, M.; Martinelli, M. Pre-treatment with berberine enhances effect of 5-fluorouracil and cisplatin in HEP2 laryngeal cancer cell line. J. Biol. Regul. Homeost. Agents 2018, 32, 167–177. [Google Scholar]
  6. Sharma, N.; Kumar, A.; Sharma, P.R.; Qayum, A.; Singh, S.K.; Dutt, P.; Paul, S.; Gupta, V.; Verma, M.K.; Satti, N.K.; et al. A new clerodane furano diterpene glycoside from Tinosporacordifolia triggers autophagy and apoptosis in HCT-116 colon cancer cells. J. Ethnopharmacol. 2018, 211, 295–310. [Google Scholar] [CrossRef]
  7. Priya, M.S.; Venkateswaran, K.V.; Vijayanand, T. Determination of apoptosis by flow cytometric analysis in MCF-7 cells treated with TinosporaCordifolia. Ind. Vet. J. 2017, 94, 73–75. [Google Scholar]
  8. Singh, B.; Sharma, P.; Kumar, A.; Chadha, P.; Kaur, R.; Kaur, A. Antioxidant and in vivo genoprotective effects of phenolic compounds identified from an endophytic Cladosporium velox and their relationship with its host plant Tinosporacordifolia. J. Ethnopharmacol. 2016, 194, 450–456. [Google Scholar] [CrossRef]
  9. Bala, M.; Pratap, K.; Verma, P.K.; Singh, B.; Padwad, Y. Validation of ethnomedicinal potential of Tinosporacordifolia for anticancer and immunomodulatory activities and quantification of bioactive molecules by HPTLC. J. Ethnopharmacol. 2015, 175, 131–137. [Google Scholar] [CrossRef]
  10. Shaikh, R.; Pund, M.; Dawane, A.; Iliyas, S. Evaluation of anticancer, antioxidant, and possible anti-inflammatory properties of selected medicinal plants used in indian traditional medication. J. Tradit. Complement. Med. 2014, 4, 253–257. [Google Scholar] [CrossRef]
  11. Maliyakkal, N.; Udupa, N.; Pai, K.S.R.; Rangarajan, A. Cytotoxic and apoptotic activities of extracts of withaniasomnifera and tinosporacordifolia in human breast cancer cells. Int. J. Appl. Res. Nat. Prod. 2013, 6, 1–10. [Google Scholar]
  12. Mishra, A.; Kumar, S.; Pandey, A.K. Scientific validation of the medicinal efficacy of tinosporacordifolia. Sci. World J. 2013, 2013, 1–8. [Google Scholar]
  13. Rashmi, K.C.; Raj, M.H.; Paul, M.; Girish, K.S.; Salimath, B.P.; Aparna, H.S. A new pyrrole based small molecule from Tinosporacordifolia induces apoptosis in MDA-MB-231 breast cancer cells via ROS mediated mitochondrial damage and restoration of p53 activity. Chem. Biol. Interact. 2019, 299, 120–130. [Google Scholar] [CrossRef] [PubMed]
  14. Mishra, R.; Kaur, G. Tinosporacordifolia Induces Differentiation and Senescence Pathways in Neuroblastoma cells. Mol. Neurobiol. 2015, 52, 719–733. [Google Scholar] [CrossRef] [PubMed]
  15. Ansari, J.A.; Rastogi, N.; Ahmad, M.K.; Mahdi, A.A.; Khan, A.R.; Thakur, R.; Srivastava, V.K.; Mishra, D.P.; Fatima, N.; Khan, H.J.; et al. ROS mediated pro-apoptotic effects of Tinosporacordifolia on breast cancer cells. Front. Biosci. 2017, 9, 89–100. [Google Scholar]
  16. Mishra, R.; Kaur, G. Aqueous ethanolic extract of Tinosporacordifolia as a potential candidate for differentiation based therapy of glioblastomas. PLoS ONE 2013, 8, 1–13. [Google Scholar] [CrossRef] [PubMed]
  17. Bansal, P.; Malik, M.A.; Das, S.N.; Kaur, J. TinosporaCordifolia Induces Cell Cycle Arrest in Human Oral Squamous Cell Carcinoma Cells. Gulf J. Oncol. 2017, 1, 10–14. [Google Scholar]
  18. Mohan, V.; Koul, A. Anticancer potential of Tinosporacordifolia and arabinogalactan against benzo(a) pyrene induced pulmonary tumorigenesis: A study in relevance to various biomarkers. J. Herbmed. Pharmacol. 2018, 7, 225–235. [Google Scholar] [CrossRef]
  19. Bakrania, A.K.; Nakka, S.; Variya, B.C.; Shah, P.V.; Patel, S.S. Antitumor potential of herbomineral formulation against breast cancer: Involvement of inflammation and oxidative stress. Indian J. Exp. Biol. 2017, 55, 680–687. [Google Scholar]
  20. Ali, H.; Dixit, S. Extraction optimization of Tinosporacordifolia and assessment of the anticancer activity of its alkaloid palmatine. Sci. World J. 2013, 2013, 1–10. [Google Scholar] [CrossRef]
  21. Jagetia, G.C.; Rao, S.K. Evaluation of the antineoplastic activity of guduchi (Tinosporacordifolia) in Ehrlich ascites carcinoma bearing mice. Biol. Pharm. Bull. 2006, 29, 460–466. [Google Scholar] [CrossRef] [PubMed]
  22. Jagetia, G.C.; Reddy, TK.; Malagi, K.J.; Nayak, B.S.; Naidu, M.B.; Ravikiran, P.B.; Kamath, S.U.; Shetty, P.C.; Reddy, D.S. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity. Phytother. Res. 2005, 19, 772–778. [Google Scholar]
  23. Mathew, S.; Kuttan, G. Immunomodulatory and antitumour activities of Tinosporacordifolia. Fitoterapia 1999, 70, 35–43. [Google Scholar] [CrossRef]
  24. Thippeswamy, G.; Salimath, B.P. Induction of caspase-3 activated DNase mediated apoptosis by hexane fraction of Tinosporacordifolia in EAT cells. Environ. Toxicol. Pharmacol. 2007, 23, 212–220. [Google Scholar] [CrossRef]
  25. Leyon, P.V.; Kuttan, G. Inhibitory effect of a polysaccharide from Tinosporacordifolia on experimental metastasis. J. Ethnopharmacol. 2004, 90, 233–237. [Google Scholar] [CrossRef]
  26. Dhanasekaran, M.; Baskar, A.A.; Ignacimuthu, S.; Agastian, P.; Duraipandiyan, V. Chemopreventive potential of Epoxy clerodane diterpene from Tinosporacordifolia against diethylnitrosamine-induced hepatocellular carcinoma. Investig. New Drugs 2009, 27, 347–355. [Google Scholar] [CrossRef]
  27. Adhvaryu, M.R.; Reddy, N.; Parabia, M.H. Anti-tumor activity of four Ayurvedic herbs in Dalton lymphoma ascites bearing mice and their short-term in vitro cytotoxicity on DLA-cell-line. Afr. J. Tradit. Complement. Altern. Med. 2008, 5, 409–418. [Google Scholar] [CrossRef] [Green Version]
  28. Singh, N.; Singh, S.M.; Shrivastava, P. Effect of Tinosporacordifolia on the antitumor activity of tumor-associated macrophages-derived dendritic cells. Immunopharmacol. Immunotoxicol. 2005, 27, 1–14. [Google Scholar]
  29. Ahamad, R.; Shrivastava, A.N.; Khan, M.A. Evaluation of in vitro anticancer activity of stem of Tinosporacordiflia against human breast cancer Vero cell lines. J. Med. Plants Stud. 2015, 3, 33–37. [Google Scholar]
Figure 1. Summary of the search strategy.
Figure 1. Summary of the search strategy.
Applsci 09 05147 g001
Table 1. Summary of the data extracted from in vitro studies.
Table 1. Summary of the data extracted from in vitro studies.
S. No.PhytocomponentsPart in UseCancer Cell LinesAnticancer Drugs Used with TcEffect on the Cancer Cells
1Berberine and isoquinolone [5]Information not providedHEP2 human laryngeal cancer cell line (in vitro)5-fluorouracil and cisplatinDecreased gene expression of cell cycle, differentiation, and epithelial–mesenchymal transition
2A new clerodane furano diterpene glycoside [6]Fresh stems
aqueous alcoholic extract
(in vitro) Human lung carcinoma cell line (A549), Prostate (PC-3), SF-269
(CNS), MDA-MB-435 (Melanoma), HCT-116 (Colon) and Breast (MCF-7)
PaclitaxelInduction of mitochondria-mediated apoptosis and autophagy in HCT-116 cells
5Information was not provided [7]stem part
aqueous and hydroalcohol extracts
Human breast carcinoma cell line MCF-7DoxorubicinInduction of apoptosis
6Phenol (ellagic acid and kaempferol) [8]Leaf and stem
Phenolic extract
CHO (Chinese Hamster Ovary) cell lineDoxorubicinMild cytotoxic effect noted at a high concentration of the extract
7N-formylannonain, magnoflorine, jatrorrhizine palmatine, 11-hydroxymustakone, cordifolioside A, tinocordiside and yangambin [9]Stem
Ethanol extract
Human cancer cell lines, KB (human oral squamous carcinoma), CHOK-1 (hamster ovary), HT-29 (human colon cancer) and SiHa (human cervical cancer) and murine primary cellsDoxorubicinCytotoxicity of cells
8Ethanol phytofraction [10]Powdered plant samples hexane, ethanol, and water extractHuman cancer cell lines HeLa-B75, HL-60, HEP-3B, PN-15,
and normal liver cell lines
SuraminCytotoxicity of cells
and induction of apoptosis
9Phytochemicals of Ethanolic extract [11]Whole plant and stem
ethanolic extracts
aqueous extracts
on human breast cancer cells (MCF7 and MDA MB 231)DoxorubicinCytotoxicity of cells,
induction of apoptosis, cell cycle arrest in the G2/M phase
11Anthraquinones, terpenoids, and saponins and phenol [12]Stem
solvents like petroleum, ether, chloroform, ethyl acetate, acetone, and water extract
prostrate (DU-145), ovary (IGROV-
1), and breast (MCF-7) cell lines
mitomycin-C (DU-145), paclitaxel against breast (MCF-7), and adriamycin (against ovary (IGR-OV-1)Cell growth inhibition
15Pyrrole-based small molecule [13]Leaves
ethyl acetate and aqueous extract
MDA-MB-231 breast cancer cellsDoxorubicinInduction of apoptosis
17Information was not provided [14]Stem
alcohol extract
human IMR-32 cell lineNoneUpregulation of senescence and apoptosis
18Phenolics contents
quercetin and rutin [15]
methanol extract
human breast cancer MDA-MB-231 cellsNoneAnti-proliferative activity
19Information was not provided [16]ethanolic extractRat C6 glioma, U87MG human glioma, PC3 prostate cancer cell line, and HeLa cell lineNoneAnti-proliferative, anti-migratory/anti-metastatic potential activity, and induction of apoptosis.
20Ready product from standard ayurvedic pharmacy [17]Information was not providedKB cancer cell linesMethotrexateCell cycle arrest at G0/G1 phase
Table 2. Summary of the data extracted from in vivo studies.
Table 2. Summary of the data extracted from in vivo studies.
S. No.PhytocomponentsPart in UseAnimalsOutcome
3Arabinogalactan a polysaccharide [18]Stem Aqueous extractMale BALB/c mice (25–30 g) benzo(a) pyrene-induced pulmonary tumorReduced tumor incidence and multiplicity, induction of apoptosis
4Phenolic component [19] Plant
semiautomated capsule
DABA-induced mammary carcinogenesis in female Sprague-Dawley rats (breast cancer)Tumor inhibition
6Phenol (ellagic acid and kaempferol) [8]Stem
phenolic extract
Freshwater air-breathing fish Channa punctatus with DNA damage induction by nonionic surfactant nonylphenolNon-cytotoxic, non-mutagenic, significant antioxidant activity, genoprotective effect
10Alkaloid palmatine [20]Stems
methanol and aqueous extracts
Swiss albino mice injected with DMBATumor inhibition
12alkaloids including berberine [21] stems dichloromethane alcoholic
Swiss albino mice injected with Ehrlich ascites carcinoma
Cytotoxicity of the cells
13Antarth [22]Plants aqueous extractmale Swiss albino mice injected with Ehrlich ascites carcinoma (EAC).Reduces the cardiotoxicity associated with doxorubicin, but independently has no anti-carcinogenic effect
14Triterpenoids and alkaloids [23]stem methanolic extractBALB RC and Swiss albino mice injected with Ehrlich ascites tumor cellsTumor inhibition
15Pyrrole-based small molecule [13]Leaves
methanolic extract
female Swiss albino mice injected with Ehrlich ascites tumor cellsReduced tumor burden and two-fold increase in survival
16Hexane fraction [24]Stems
solvents like hexane, benzene and chloroform
Swiss albino female mice injected intraperitoneally with Ehrlich ascites tumor (EAT) cellsCell growth inhibition and induction of apoptosis
20Polysaccharide [25]Stem
methanolic extract
C57BL/6 MICE injected by B16F-10 melanoma cell linesTumor inhibition
21Clerodane-derived diterpenoids [26]Stems
alcoholic extraction
Male Wistar albino strain rats with diethylnitrosamine-induced hepatocellular carcinomaInhibiting tumor growth by blocking carcinogen metabolic activation and enhancing carcinogen detoxification.
22Crude powder [27] hydroethanolic (1:1) extractDalton lymphoma ascites (DLA) tumor model in Swiss albino miceReduced clonogenicity
23Information was not provided [28] Plant alcoholic extractInbred BALB/c mice
tumor-associated macrophage (TAM)-derived dendritic cell to Dalton’s lymphoma-bearing mice
Enhances the differentiation of dendritic cells

Share and Cite

MDPI and ACS Style

Deepa, B.; Babaji, H.V.; Hosmani, J.V.; Alamir, A.W.H.; Mushtaq, S.; Raj, A.T.; Patil, S. Effect of Tinospora cordifolia-Derived Phytocomponents on Cancer: A Systematic Review. Appl. Sci. 2019, 9, 5147.

AMA Style

Deepa B, Babaji HV, Hosmani JV, Alamir AWH, Mushtaq S, Raj AT, Patil S. Effect of Tinospora cordifolia-Derived Phytocomponents on Cancer: A Systematic Review. Applied Sciences. 2019; 9(23):5147.

Chicago/Turabian Style

Deepa, Babji, Harsha V. Babaji, Jagadish V. Hosmani, Abdul Wahab H. Alamir, Shazia Mushtaq, A. Thirumal Raj, and Shankargouda Patil. 2019. "Effect of Tinospora cordifolia-Derived Phytocomponents on Cancer: A Systematic Review" Applied Sciences 9, no. 23: 5147.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop